Multitarget μ-Opioid Receptor Agonists─Neuropeptide FF Receptor Antagonists Induce Potent Antinociception with Reduced Adverse Side Effects-Reference-Cited by-同舟云学术

Multitarget μ-Opioid Receptor Agonists─Neuropeptide FF Receptor Antagonists Induce Potent Antinociception with Reduced Adverse Side Effects

Published:2024-04-30 Issue:9 Volume:67 Page:7603-7619
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

De Neve Jolien¹,Elhabazi Khadija²,Gonzalez Simon¹,Herby Claire³,Schneider Séverine³,Utard Valérie²,Fellmann-Clauss Rosine²,Petit-Demouliere Nathalie²,Lecat Sandra²,Kremer Mélanie⁴,Ces Aurelia⁴,Daubeuf François⁵,Martin Charlotte¹,Ballet Steven¹^ORCID,Bihel Frédéric³^ORCID,Simonin Frédéric²^ORCID

Affiliation:

1. Research Group of Organic Chemistry, Departments of Chemistry and Bioengineering Sciences, Vrije Universiteit Brussel, 1050 Brussels, Belgium

2. Biotechnologie et Signalisation Cellulaire, UMR 7242, Centre National de la Recherche Scientifique, Université de Strasbourg, 67400 Illkirch, France

3. Laboratoire d’Innovation Thérapeutique, Faculté de Pharmacie, UMR 7200, Centre National de la Recherche Scientifique, Université de Strasbourg, 67400 Illkirch, France

4. Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives (INCI), 67000 Strasbourg, France

5. Plateforme de Chimie Biologique Intégrative de Strasbourg, UAR 3286, Centre National de la Recherche Scientifique, Université de Strasbourg, 67400 Illkirch, France

Funder

Agence Nationale de la Recherche

Vrije Universiteit Brussel

Fonds Wetenschappelijk Onderzoek

Centre National de la Recherche Scientifique

Industrial Research Fund Flanders

SATT Conectus

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c00442

Reference45 articles.

1. Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors

2. A bifunctional-biased mu-opioid agonist–neuropeptide FF receptor antagonist as analgesic with improved acute and chronic side effects

3. Is Europe also facing an opioid crisis?—A survey of European Pain Federation chapters

4. Targeting multiple opioid receptors – improved analgesics with reduced side effects?

5. Hybrid Opioid/Non-Opioid Ligands in Pain Research